相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Jasmin Mettler et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer
Seung Hwan Moon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients
Mubarik A. Arshad et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma
Sungwon Kim et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma
Domenico Albano et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
Anne-Segolene Cottereau et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival
Aatif Parvez et al.
ANNALS OF NUCLEAR MEDICINE (2018)
Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma
Julian M. M. Rogasch et al.
BMC CANCER (2018)
Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer
Hyunjin Park et al.
CLINICAL CANCER RESEARCH (2018)
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL)
Qian Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET
Fanny Orlhac et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Heterogeneity and irregularity of pretreatment 18F-fluorodeoxyglucose positron emission tomography improved prognostic stratification of p16-negative high-risk squamous cell carcinoma of the oropharynx
Nai-Ming Cheng et al.
ORAL ONCOLOGY (2018)
Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor
Sehhoon Park et al.
PLOS ONE (2018)
Scalable training of artificial neural networks with adaptive sparse connectivity inspired by network science
Decebal Constantin Mocanu et al.
NATURE COMMUNICATIONS (2018)
Radiomics analysis of pre-treatment [F-18]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
E. J. van Helden et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun et al.
LANCET ONCOLOGY (2018)
Convolutional neural networks: an overview and application in radiology
Rikiya Yamashita et al.
INSIGHTS INTO IMAGING (2018)
The significance of intertumor and intratumor heterogeneity in liver cancer
Jinping Liu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Predictive value of 18F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial
Stephanie Becker et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
Alison J. Moskowitz et al.
BLOOD (2017)
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma
Anne-Segolene Cottereau et al.
CLINICAL CANCER RESEARCH (2016)
Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
N. George Mikhaeel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
Michel Meignan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Applications and limitations of radiomics
Stephen S. F. Yip et al.
PHYSICS IN MEDICINE AND BIOLOGY (2016)
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
Luca Ceriani et al.
BLOOD (2015)
Multi-Layer and Recursive Neural Networks for Metagenomic Classification
Gregory Ditzler et al.
IEEE TRANSACTIONS ON NANOBIOSCIENCE (2015)
Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F] FDG PET to Predict Survival in Hodgkin Lymphoma
Salim Kanoun et al.
PLOS ONE (2015)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
M. Dreyling et al.
ANNALS OF ONCOLOGY (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Silvia Bea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome
Maroun Karam et al.
NUCLEAR MEDICINE COMMUNICATIONS (2009)
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster et al.
BLOOD (2008)